- Home
- DECK vs DXCM Comparison
DECK vs DXCM Comparison
Compare DECK & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DECK
- DXCM
- Stock Information
- Founded
- DECK 1973
- DXCM 1999
- Country
- DECK United States
- DXCM United States
- Employees
- DECK N/A
- DXCM N/A
- Industry
- DECK Shoe Manufacturing
- DXCM Medical/Dental Instruments
- Sector
- DECK Consumer Discretionary
- DXCM Health Care
- Exchange
- DECK Nasdaq
- DXCM Nasdaq
- Market Cap
- DECK 30.8B
- DXCM 28.0B
- IPO Year
- DECK 1993
- DXCM 2005
- Fundamental
- Price
- DECK $208.01
- DXCM $80.24
- Analyst Decision
- DECK Buy
- DXCM Buy
- Analyst Count
- DECK 21
- DXCM 17
- Target Price
- DECK $183.77
- DXCM $98.00
- AVG Volume (30 Days)
- DECK 1.7M
- DXCM 3.4M
- Earning Date
- DECK 01-30-2025
- DXCM 02-06-2025
- Dividend Yield
- DECK N/A
- DXCM N/A
- EPS Growth
- DECK 46.79
- DXCM 83.21
- EPS
- DECK 5.68
- DXCM 1.67
- Revenue
- DECK $4,656,732,000.00
- DXCM $3,954,000,000.00
- Revenue This Year
- DECK $16.54
- DXCM $13.10
- Revenue Next Year
- DECK $10.89
- DXCM $14.74
- P/E Ratio
- DECK $36.62
- DXCM $48.12
- Revenue Growth
- DECK 19.25
- DXCM 16.19
- 52 Week Low
- DECK $108.65
- DXCM $62.34
- 52 Week High
- DECK $214.70
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- DECK 62.90
- DXCM 58.78
- Support Level
- DECK $201.00
- DXCM $74.50
- Resistance Level
- DECK $214.70
- DXCM $81.51
- Average True Range (ATR)
- DECK 5.71
- DXCM 2.57
- MACD
- DECK -0.81
- DXCM -0.10
- Stochastic Oscillator
- DECK 65.23
- DXCM 81.88
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2024, Ugg and Hoka accounted for 52% and 42% of total sales, respectively. The firm also markets niche brands Teva, Ahnu, and Koolaburra. Deckers generates most of its sales through wholesale partnerships, but also operates e-commerce in more than 50 countries and about 178 company-operated stores. The company generated 67% of its fiscal 2024 sales in the United States.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.